Free Trial

SpringWorks Therapeutics (SWTX) Earnings Date, Estimates & Call Transcripts

SpringWorks Therapeutics logo
$35.59 +0.81 (+2.33%)
(As of 12/20/2024 05:16 PM ET)

SpringWorks Therapeutics Latest Earnings Summary

Actual EPS
(Nov. 12)
-$0.72 Beat By $0.03
Consensus EPS
(Nov. 12)
-$0.75

SpringWorks Therapeutics issued Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.72, which topped analysts' consensus estimates of -$0.75 by $0.03. Quarterly revenue rose 4810.0% year-over-year to $49.10 million, below the consensus estimate of $53.28 million. With a trailing EPS of -$3.88, SpringWorks Therapeutics' earnings are expected to grow next year, from ($3.12) to ($2.08) per share.

Get SpringWorks Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on SpringWorks Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

SWTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

SWTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

SpringWorks Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242-$1.27-$1.10-$1.19
Q2 20242-$1.44-$0.99-$1.22
Q3 20242-$0.74-$0.60-$0.67
Q4 20242-$0.76-$0.59-$0.68
FY 20248-$4.21-$3.28-$3.75
Q1 20252-$0.75-$0.44-$0.60
Q2 20252-$0.71-$0.23-$0.47
Q3 20252-$0.60-$0.03-$0.32
Q4 20252-$0.46$0.11-$0.18
FY 20258($2.52)($0.59)($1.56)

SpringWorks Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/12/2024Q3 2024-$0.75-$0.72+$0.03-$0.72$53.28M$49.10M
8/7/2024Q2 2024-$1.12-$0.54+$0.58-$0.54$34.42M$59.73M
5/2/2024Q1 2024-$1.17-$1.18 -$0.01-$1.18$12.07M$21.00M
2/27/2024Q4 2023-$1.24-$1.44 -$0.20-$1.44$1.26M$5.45M
11/2/2023Q3 2023-$1.31-$1.27+$0.04-$1.27--
8/2/2023Q2 2023-$1.26-$1.25+$0.01-$1.25--
Trump’s Sending THIS Crypto Higher on Purpose (Ad)

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

5/3/2023Q1 2023-$1.10-$1.18 -$0.08-$1.18--
2/28/2023Q4 2022-$1.01-$1.19 -$0.18-$1.19--

SpringWorks Therapeutics Earnings - Frequently Asked Questions

SpringWorks Therapeutics (NASDAQ:SWTX) last announced its quarterly earning data on Tuesday, November 12, 2024. Learn more on SWTX's earnings history.

In the previous quarter, SpringWorks Therapeutics (NASDAQ:SWTX) reported ($0.72) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.75) by $0.03. Learn more on analysts' earnings estimate vs. SWTX's actual earnings.

The conference call for SpringWorks Therapeutics's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for SpringWorks Therapeutics's latest earnings report can be read online.
Read Transcript

SpringWorks Therapeutics's earnings report can be found in their filing with the SEC.
View SEC filing

SpringWorks Therapeutics (NASDAQ:SWTX) has a recorded annual revenue of $135.49 million.

SpringWorks Therapeutics (NASDAQ:SWTX) has a recorded net income of -$325.10 million. SWTX has generated -$3.88 earnings per share over the last four quarters.

SpringWorks Therapeutics's earnings are expected to grow from ($3.12) per share to ($2.08) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:SWTX) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners